Home › Overweight
Overweight clinical trials recruiting in the U.S.
209 studies for Overweight are recruiting participants at sites across the United States.
Cities with the most studies
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL29 studies
- Orlando, FL27 studies
- Dallas, TX23 studies
- Miami, FL23 studies
- Washington, DC20 studies
- Atlanta, GA20 studies
- Austin, TX19 studies
- Las Vegas, NV19 studies
- Jacksonville, FL19 studies
- New York City, NY19 studies
- Los Angeles, CA18 studies
- Tucson, AZ17 studies
- Baltimore, MD16 studies
- Birmingham, AL16 studies
- St. Louis, MO16 studies
- Louisville, KY15 studies
- Charlotte, NC15 studies
- Concord, CA15 studies
- Havelock, NC15 studies
- San Diego, CA14 studies
- Wilmington, NC14 studies
- Roswell, GA14 studies
- Indianapolis, IN14 studies
- Cincinnati, OH14 studies
- Phoenix, AZ13 studies
- Honolulu, HI13 studies
- Philadelphia, PA13 studies
- Rochester, NY13 studies
- Farmington Hills, MI12 studies
- Columbus, OH12 studies
- Johns Creek, GA12 studies
- Nashville, TN12 studies
- Arlington, VA12 studies
- Deltona, FL12 studies
- Escondido, CA11 studies
- Greensboro, NC11 studies
- Salt Lake City, UT11 studies
- The Woodlands, TX10 studies
By state
- Alabama31 studies
- Arizona29 studies
- Arkansas7 studies
- California69 studies
- Colorado11 studies
- Connecticut16 studies
- District of Columbia7 studies
- Florida60 studies
- Georgia38 studies
- Hawaii13 studies
- Idaho20 studies
- Illinois40 studies
- Indiana18 studies
- Iowa10 studies
- Kansas27 studies
- Kentucky23 studies
- Louisiana24 studies
- Maryland36 studies
- Massachusetts22 studies
- Michigan21 studies
- Minnesota11 studies
- Mississippi12 studies
- Missouri35 studies
- Montana6 studies
- Nebraska6 studies
- Nevada20 studies
- New Hampshire3 studies
- New Jersey13 studies
- New Mexico5 studies
- New York44 studies
- North Carolina40 studies
- North Dakota8 studies
- Ohio33 studies
- Oklahoma18 studies
- Oregon13 studies
- Pennsylvania32 studies
- Rhode Island11 studies
- South Carolina32 studies
- South Dakota3 studies
- Tennessee24 studies
- Texas57 studies
- Utah18 studies
- Virginia34 studies
- Washington23 studies
- Wisconsin8 studies
Recently updated studies
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
RecruitingPhase 2Healthy volunteers welcome
Ages 18 to 60 · Women · Updated Nov 12, 2026 · NCT03407079Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain
Recruiting
Ages 18 to 75 · All sexes · Updated Nov 10, 2026 · NCT07708064Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07830329Time Restricted Eating (TRE) in Bipolar Disorder
Recruiting
Ages 18 to 65 · All sexes · Updated Nov 10, 2026 · NCT07211217Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Nov 9, 2026 · NCT07871409A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351045A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351058Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07685808Metabolic Health, Bones and Nuts During Weight Loss in Adults
RecruitingHealthy volunteers welcome
Ages 50 to 75 · All sexes · Updated Nov 6, 2026 · NCT06949280Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Nov 6, 2026 · NCT07575399A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity
RecruitingPhase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07876531A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07823608A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07845500Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07866066A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07843498A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07843485A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07919678A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07595549Confident Moves Intervention Efficacy Trial: Obesity Care Settings
Recruiting
Ages 18 to 64 · All sexes · Updated Nov 4, 2026 · NCT07623772A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07881458A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06857942A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07392190From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.